These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20860636)

  • 1. Should we focus on novel risk markers and screening tests to better predict and prevent cardiovascular disease? Or are we putting the cart before the horse?
    Wong ND
    Prev Cardiol; 2010; 13(4):149-51. PubMed ID: 20860636
    [No Abstract]   [Full Text] [Related]  

  • 2. Should we focus on novel risk markers and screening tests to better predict and prevent cardiovascular disease? Point.
    Enriquez JR; de Lemos JA
    Prev Cardiol; 2010; 13(4):152-9. PubMed ID: 20860637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac biomarkers in haemodialysis patients: the prognostic value of amino-terminal pro-B-type natriuretic peptide and cardiac troponin T.
    Sommerer C; Giannitsis E; Schwenger V; Zeier M
    Nephron Clin Pract; 2007; 107(3):c77-81. PubMed ID: 17890874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple biomarkers and cardiovascular risk.
    Austin MJ; Heneghan MA
    N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
    [No Abstract]   [Full Text] [Related]  

  • 5. Biomarkers for coronary heart disease clinical risk prediction: a critical appraisal. Counterpoint.
    Wilkins JT; Lloyd-Jones DM
    Prev Cardiol; 2010; 13(4):160-5. PubMed ID: 20860638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple biomarker panels for cardiovascular risk assessment.
    de Lemos JA; Lloyd-Jones DM
    N Engl J Med; 2008 May; 358(20):2172-4. PubMed ID: 18480211
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognostic significance of markers in combination.
    SoRelle R
    Circulation; 2003 Jul; 108(3):e9004-5. PubMed ID: 12876139
    [No Abstract]   [Full Text] [Related]  

  • 8. Use of cardiac biomarkers in end-stage renal disease.
    Wang AY; Lai KN
    J Am Soc Nephrol; 2008 Sep; 19(9):1643-52. PubMed ID: 18322158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-terminal-pro-B-type natriuretic peptide: universal marker of cardiovascular risk?
    Richards AM; Frampton CM
    Circulation; 2005 Jul; 112(1):9-11. PubMed ID: 15998694
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.
    Zethelius B; Berglund L; Sundström J; Ingelsson E; Basu S; Larsson A; Venge P; Arnlöv J
    N Engl J Med; 2008 May; 358(20):2107-16. PubMed ID: 18480203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Value of biological markers in cardiovascular disease].
    Couderc R; Lefevre G; Fiessinger JN
    Bull Acad Natl Med; 2012 Jan; 196(1):217-22. PubMed ID: 23259345
    [No Abstract]   [Full Text] [Related]  

  • 12. Are multiple biomarker testing strategies ready for prime time in heart failure?
    Lee DS; Tu JV
    Circ Heart Fail; 2009 Sep; 2(5):387-8. PubMed ID: 19808366
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular risk prediction by N-terminal pro brain natriuretic peptide and high sensitivity C-reactive protein is affected by age and sex.
    Olsen MH; Hansen TW; Christensen MK; Gustafsson F; Rasmussen S; Wachtell K; Ibsen H; Torp-Pedersen C; Hildebrandt PR
    J Hypertens; 2008 Jan; 26(1):26-34. PubMed ID: 18090537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multimarker risk stratification approach to non-ST elevation acute coronary syndrome: implications of troponin T, CRP, NT pro-BNP and fibrin D-dimer levels.
    Tello-Montoliu A; Marín F; Roldán V; Mainar L; López MT; Sogorb F; Vicente V; Lip GY
    J Intern Med; 2007 Dec; 262(6):651-8. PubMed ID: 17986200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Troponin-T and N-terminal pro-B-type natriuretic peptide predict mortality benefit from coronary revascularization in acute coronary syndromes: a GUSTO-IV substudy.
    James SK; Lindbäck J; Tilly J; Siegbahn A; Venge P; Armstrong P; Califf R; Simoons ML; Wallentin L; Lindahl B
    J Am Coll Cardiol; 2006 Sep; 48(6):1146-54. PubMed ID: 16978997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic efficacy of cardiac biomarkers for mortality in dialysis patients.
    Hickman PE; McGill DA; Talaulikar G; Hiremagalur B; Bromley J; Rahman A; Koerbin G; Southcott E; Potter JM
    Intern Med J; 2009 Dec; 39(12):812-8. PubMed ID: 20233242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes.
    Heeschen C; Hamm CW; Mitrovic V; Lantelme NH; White HD;
    Circulation; 2004 Nov; 110(20):3206-12. PubMed ID: 15533869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. N-terminal brain natriuretic peptide predicted cardiovascular events stronger than high-sensitivity C-reactive protein in hypertension: a LIFE substudy.
    Olsen MH; Wachtell K; Nielsen OW; Hall C; Wergeland R; Ibsen H; Kjeldsen SE; Devereux RB; Dahlöf B; Hildebrandt PR
    J Hypertens; 2006 Aug; 24(8):1531-9. PubMed ID: 16877955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interrelationship between preoperative anemia and N-terminal pro-B-type natriuretic peptide: the effect on predicting postoperative cardiac outcome in vascular surgery patients.
    Goei D; Flu WJ; Hoeks SE; Galal W; Dunkelgrun M; Boersma E; Kuijper R; van Kuijk JP; Winkel TA; Schouten O; Bax JJ; Poldermans D
    Anesth Analg; 2009 Nov; 109(5):1403-8. PubMed ID: 19843778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative cardiac risk assessment in noncardiac surgery: are natriuretic peptides the magic bullet?
    Bolliger D; Seeberger MD; Filipovic M
    J Am Coll Cardiol; 2009 Oct; 54(17):1607-8. PubMed ID: 19833259
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.